Thoratec

ServiceTitan Appoints Michele O’Connor as Chief Accounting Officer

Retrieved on: 
Tuesday, January 16, 2024
Technology, Finance, Other Technology, Accounting, Professional Services, Software, Internet, Data Analytics, Data Management, Other Professional Services, Thoratec, KPMG, Ara, Multimedia, Vahe, Factor of safety, Pest control, Comptroller, IPO, HVAC, Electricity, Audit committee

ServiceTitan , a software platform built to power the trades, today announced Michele O’Connor as its new Chief Accounting Officer (CAO).

Key Points: 
  • ServiceTitan , a software platform built to power the trades, today announced Michele O’Connor as its new Chief Accounting Officer (CAO).
  • O’Connor most recently served as Chief Accounting Officer at Veeva Systems, and was a key leader in driving the preparation and public company readiness process for their IPO in October 2013.
  • O’Connor will be responsible for the oversight of all global accounting and finance operations.
  • View the full release here: https://www.businesswire.com/news/home/20240116403757/en/
    Michele O'Connor, Chief Accounting Officer at ServiceTitan (Photo: Business Wire)
    “At ServiceTitan, we’re committed to building a team of leaders with the experience and expertise necessary to ensure our success, and most importantly the success of our customers," said Dave Sherry, Chief Financial Officer at ServiceTitan.

Vensana Capital Strengthens Team with Promotions and Addition of Venture Partner

Retrieved on: 
Thursday, January 4, 2024
Other Professional Services, Finance, Health, Consulting, Health Technology, Professional Services, Technology, Other Technology, Yee, Navigant Consulting, Associate, Piper Sandler Companies, Coronary thrombosis, ATS Medical, Thoratec, Cardiology, EV3, Biotechnology, CFO, Partner, Acquisition, Boston Scientific, Medtech, NEA, Amrinder Singh, Therapy, MGM+, Medtronic, Engineering, Elective surgery, Investment, IPO, KPMG, Patient, CRG, Capital, Neurology, DSM-IV codes, Management

Vensana Capital , a leading medical technology-focused venture capital and growth equity investment firm, today announced the promotions of Amrinder Singh, Cynthia Yee, Greg Banker, and Mike Kramer to Partner and Steve Schwen to Partner & Chief Financial Officer.

Key Points: 
  • Vensana Capital , a leading medical technology-focused venture capital and growth equity investment firm, today announced the promotions of Amrinder Singh, Cynthia Yee, Greg Banker, and Mike Kramer to Partner and Steve Schwen to Partner & Chief Financial Officer.
  • The firm also announced the addition of veteran medtech leader Bill Hoffman as a Venture Partner.
  • “Since launching Vensana in 2019, we have set out to build the deepest, most experienced team in our sector.
  • Bill Hoffman joins Vensana Capital as a Venture Partner.

Cutera, Inc. Appoints Taylor Harris as Chief Executive Officer

Retrieved on: 
Thursday, July 27, 2023
Cosmetics, Retail, Health, General Health, Clinical Trials, Pharmaceutical, Biotechnology, Treasury, Interim, JPMorgan Chase, Senior, Information technology, Bristol Myers Squibb, Sale, Accounting, Dermatology, Zeltiq Aesthetics, Growth, Thoratec, Management

CUTERA, INC. (“Cutera” or the “Company”) (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today announced that Taylor Harris has been appointed Chief Executive Officer, effective August 7, 2023.

Key Points: 
  • CUTERA, INC. (“Cutera” or the “Company”) (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today announced that Taylor Harris has been appointed Chief Executive Officer, effective August 7, 2023.
  • Mr. Harris will succeed Sheila Hopkins, who has been serving as Interim Chief Executive Officer since April 2023.
  • Mr. Harris and Ms. Hopkins will both continue serving as members of Cutera’s Board of Directors.
  • He most recently served as Senior Vice President and Chief Financial Officer of MyoKardia, a clinical-stage biopharmaceutical company, until the company’s sale to Bristol Myers Squibb in 2020.

Treace Appoints Julie Dewey as Chief Communications and Investor Relations Officer

Retrieved on: 
Wednesday, July 12, 2023
Thoratec, Extremities, Pepperdine University, IR, University, Stryker, Marketing, 3D, Corporate communication, Organization, Medtronic, Wright, Bunion, Institutional Investor, Management, Treace Medical Concepts

“Julie is a talented and well-respected corporate communications leader who we are thrilled to welcome to Treace,” said John T. Treace, CEO, Founder and Board Member of Treace.

Key Points: 
  • “Julie is a talented and well-respected corporate communications leader who we are thrilled to welcome to Treace,” said John T. Treace, CEO, Founder and Board Member of Treace.
  • Prior to Nevro, she was Senior Vice President and Chief Communications Officer of Wright Medical Group, N.V., a leading orthopaedic company focused on extremities and biologics, which was acquired by Stryker.
  • While at Wright, she built a world-class investor relations program that was the highest ranked small-mid cap medical device IR program by Institutional Investor for a record five consecutive years.
  • Earlier in her career, Ms. Dewey held investor relations and marketing positions at ev3 Inc. (acquired by Covidien/Medtronic), Kyphon Inc. (acquired by Medtronic) and Thoratec Corporation (acquired by St. Jude/Abbott).

Cognito Therapeutics Announces Key Medical and Technology Leadership Appointments as Late-Stage Neurotechnology Platform Advances

Retrieved on: 
Monday, April 17, 2023
Software, Research, Pharmaceutical, Consumer, Technology, Medical Devices, Health Technology, Clinical Trials, Science, Biotechnology, Seniors, Health, Other Science, Epilepsy, University College London Hospitals NHS Foundation Trust, University College London, Genzyme, University, Education, HOPE, Biogen, Abbott, Disease, Electrical engineering, Program management, Sale, Trial of the century, Neurophysiology, PMA, Novartis, Mount Sinai Hospital, Patient, Evaluation, Hospital, EEG, McGill University, Philips, IDE, SVP, Therapy, Thoratec, Management, Nursing, Pharmaceutical industry, Cognito, Engineering, Queen's University, Northeastern University

Cognito Therapeutics , today announced executive leadership team appointments with Ralph Kern, M.D., as Chief Medical Officer and Kim Kwan as Chief Technology Officer who has been promoted from VP of Engineering.

Key Points: 
  • Cognito Therapeutics , today announced executive leadership team appointments with Ralph Kern, M.D., as Chief Medical Officer and Kim Kwan as Chief Technology Officer who has been promoted from VP of Engineering.
  • “I am thrilled to welcome Ralph to the Cognito team, and the promotion of Kim to the role of Chief Technology Officer.
  • Their collective expertise and leadership across our medical, technology and engineering divisions will be invaluable as we advance our non-invasive pivotal HOPE study evaluating our proprietary neuromodulation device in Alzheimer’s Disease,” said Brent Vaughan, CEO, Cognito Therapeutics.
  • Ralph Kern, M.D., MHSc, is Chief Medical Officer at Cognito Therapeutics.

Cannon Quality Group Names Jeff Flint and Josh Tucker Regional Directors

Retrieved on: 
Wednesday, November 9, 2022
Organization, Biomedical engineering, University, Industry, Novartis, FDA, Compliance, CQG, Thoratec, University of Utah, Master, San Francisco Bay Area, Southern Polytechnic State University, Engineering, GE Healthcare, LLC, Mechanical, ISO, Quality management system, Biomedicine, Efficiency, Quality of life, Management, Medical device, Medicine, Science

DANVILLE, Calif., Nov. 9, 2022 /PRNewswire/ -- Cannon Quality Group, LLC ( https://www.cannonqualitygroup.com ) today announced that the company has appointed Jeff Flint and Josh Tucker as Regional Directors of the west and east coasts respectively ( https://www.cannonqualitygroup.com/meet-our-team ), effective immediately.

Key Points: 
  • DANVILLE, Calif., Nov. 9, 2022 /PRNewswire/ -- Cannon Quality Group, LLC ( https://www.cannonqualitygroup.com ) today announced that the company has appointed Jeff Flint and Josh Tucker as Regional Directors of the west and east coasts respectively ( https://www.cannonqualitygroup.com/meet-our-team ), effective immediately.
  • Mr. Flint has served as Senior Quality Director at Cannon Quality Group since May 2021.
  • "I am excited to be continuing my relationship with the Cannon Quality Group in the role of Western Regional Director of Quality" said Mr.
  • Since July 2021, Mr. Tucker has served as Sr. Quality Manager at Cannon Quality Group.

CooperCompanies Appoints Cynthia Lucchese to Board of Directors

Retrieved on: 
Monday, October 3, 2022
Workforce, The Cooper Companies, Guidant, Trustee, Board of directors, Lucchese, Fertility, Audit committee, Thoratec, CEO, Health, Hulman, Boston Scientific, Business administration, Committee, Corporate governance, CA, Association of Corporate Treasurers, Cooper, Genomics, Accounting, CooperVision, NYSE, SAN, Penske Corporation, Hulman & Company, Eli Lilly and Company, Master of Business Administration, Board, Woman, Bachelor of Science, Finance, GLOBE, Management, Company, Science, Indiana University

SAN RAMON, Calif., Oct. 03, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) announced today that its Board of Directors has appointed Cynthia Lucchese as an independent director, effective October 1, 2022.

Key Points: 
  • SAN RAMON, Calif., Oct. 03, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) announced today that its Board of Directors has appointed Cynthia Lucchese as an independent director, effective October 1, 2022.
  • Lucchese has also been appointed to serve on the Audit Committee and Corporate Governance and Nominating Committee when she joins the Board.
  • We are pleased to welcome Cindy to Coopers Board of Directors, said Al White, President and CEO of CooperCompanies.
  • Lucchese serves on the Boards of Directors of Inari Medical Inc. and Beaver-Visitec International Holdings.

Plume Announces Three New Independent Directors to its Board

Retrieved on: 
Wednesday, June 8, 2022
Aurora, Tele-Communications Inc., Goal, CFO, CTO, U.S. Venture Partners, Silicon, Multimedia, CPE, Thoma Bravo, Thoratec, Engineering, Concert Communications Services, CO, View, Internet access, Name, The New York Times, Human, Marketing, CSP, CEO, Alpha Girls, Fahri, OpenSync Framework, CallidusCloud, Liberty Global, Aïn Oulmane District, Wi-Fi, IOS SDK, Xperience, CSPS, TCI, Aurora Network, Initial public offering, Rogers Communications, Service provider, Senior, Acquisition, SoFi, Qwest, Xfinity, Small business, PALO, Software as a service, Woman, Qualcomm, Executive, IPO, New economy, Love, SoftBank Group, IOT, Telematics, Samsung, Tablet, Insight Partners, Board, Audit committee, Management, Salesforce, Plume, Medallia, Technology, Comcast

PALO ALTO, Calif., June 8, 2022 /PRNewswire/ -- Plume®, the personalized communications services pioneer, today announced that it has appointed Magdalena Yesil, Founding Board Member of Salesforce, Roxanne Oulman, former Executive Vice President and CFO at Medallia and Tony Werner, former CTO at Comcast, as independent directors to its board.

Key Points: 
  • "I've long shared Fahri's vision, and appreciated Plume's ambitions in reconstructing residential and small business service bundles," said Tony Werner.
  • Plume is revolutionizing connectivity and the smart home experience with an open platform, hardware agnostic approach.
  • I am excited to continue partnering with Fahri, and help the Plume team achieve their goals in transforming smart spaces globally."
  • "I couldn't be more excited and honored to welcome Magdalena, Roxanne and Tony to Plume," said Fahri Diner, Founder and CEO of Plume.

Plume Announces Three New Independent Directors to its Board

Retrieved on: 
Wednesday, June 8, 2022
Aurora, Tele-Communications Inc., Goal, CFO, CTO, U.S. Venture Partners, Silicon, CPE, Thoma Bravo, Thoratec, Engineering, Concert Communications Services, CO, Internet access, Name, The New York Times, Human, Marketing, CSP, CEO, Alpha Girls, Fahri, OpenSync Framework, CallidusCloud, Liberty Global, Aïn Oulmane District, Wi-Fi, IOS SDK, Xperience, CSPS, TCI, Aurora Network, Initial public offering, Rogers Communications, Service provider, Senior, Acquisition, SoFi, Qwest, Xfinity, Small business, PALO, Software as a service, Woman, Qualcomm, Executive, IPO, New economy, Love, SoftBank Group, IOT, Telematics, Samsung, Tablet, Insight Partners, Board, Audit committee, Management, Salesforce, Plume, Medallia, Technology, Comcast

PALO ALTO, Calif., June 8, 2022 /PRNewswire/ -- Plume®, the personalized communications services pioneer, today announced that it has appointed Magdalena Yesil, Founding Board Member of Salesforce, Roxanne Oulman, former Executive Vice President and CFO at Medallia and Tony Werner, former CTO at Comcast, as independent directors to its board.

Key Points: 
  • "I've long shared Fahri's vision, and appreciated Plume's ambitions in reconstructing residential and small business service bundles," said Tony Werner.
  • I am excited to continue partnering with Fahri, and help the Plume team achieve their goals in transforming smart spaces globally."
  • "I couldn't be more excited and honored to welcome Magdalena, Roxanne and Tony to Plume," said Fahri Diner, Founder and CEO of Plume.
  • Plume leverages OpenSync, an open-source framework that comes pre-integrated and supported on the leading silicon, CPE, and platform SDKs.

Nanomix Appoints Vidur Sahney as Chief Operating Officer

Retrieved on: 
Wednesday, March 30, 2022
Other Health, Hospitals, Health, Other Technology, Technology, Company, Thoratec, St. Jude Medical, III, CE, Class, Forward-looking statement, Growth, Research, Decision-making, OTCBB, Corporation, Mechanical, San Francisco State University, Food, U.S. Securities and Exchange Commission, Laboratory, Health, Industry, Food and Drug Administration, Elab, Time, COVID-19, Juul, Engineering, JUUL, FDA, Operation, Acquisition, Security (finance), Management, Medical device, Science

Nanomix Corporation (OTCBB: NNMX, NNMXD), a leader in the development of mobile, affordable, point-of-care diagnostics, announces the appointment of Vidur Sahney as Chief Operating Officer.

Key Points: 
  • Nanomix Corporation (OTCBB: NNMX, NNMXD), a leader in the development of mobile, affordable, point-of-care diagnostics, announces the appointment of Vidur Sahney as Chief Operating Officer.
  • Mr. Sahney brings to Nanomix more than 20 years of experience in operations, quality, validation, manufacturing and research.
  • In this newly created executive management position, Mr. Sahney will manage and be responsible for Nanomix operations including manufacturing, assay development and quality.
  • Vidur is an accomplished operational executive and I am proud to welcome him to the Nanomix management team.